Enhancing Respiratory Syncytial Virus Immunoprophylaxis: Addressing Challenges Beyond Palivizumab in the Gulf Region. [PDF]
Babar A.
europepmc +1 more source
Audit of linkage to care and administration of immunoprophylaxis to infants born to mothers with chronic hepatitis B infection at Monash Health 2014-2022. [PDF]
Lenihan C +3 more
europepmc +1 more source
Key Indications for Passive Immune Prophylaxis Against SARS-CoV-2 Infection in Malignant Hematological Disorders: An Analytic Hierarchy Process by an Ad Hoc Italian Expert Panel. [PDF]
Marchetti M +8 more
europepmc +1 more source
Adherence to Palivizumab for Respiratory Syncytial Virus Prophylaxis in Romanian Infants. [PDF]
Calomfirescu-Avramescu A +4 more
europepmc +1 more source
Exploring the impact of hepatitis B immunoglobulin and antiviral interventions to reduce vertical transmission of hepatitis B virus. [PDF]
Wibowo DP +4 more
europepmc +1 more source
Respiratory Syncytial Virus: A Narrative Review of Updates and Recent Advances in Epidemiology, Pathogenesis, Diagnosis, Management and Prevention. [PDF]
Asseri AA.
europepmc +1 more source
A new milestone in the fight against RSV disease in infants: continuous vigilance is needed. [PDF]
Priante E, Baraldi E.
europepmc +1 more source
Respiratory Syncytial Virus Burden in Premature Infants: The Role of Season With and Without RSV Immunoprophylaxis in a Multicenter Study. [PDF]
Domany KA +18 more
europepmc +1 more source

